HIV pre-exposure prophylaxis for women
Women and girls comprise nearly half of HIV-infected individuals globally and 20% of new infections in the United States, indicating an urgent need to optimise HIV prevention options in this population. HIV pre-exposure prophylaxis (PrEP) – where antiretrovirals are administered to HIV-non-infected...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2016-07-01
|
| Series: | Journal of Virus Eradication |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2055664020304581 |
| _version_ | 1818429784142643200 |
|---|---|
| author | Anandi N. Sheth Charlotte P. Rolle Monica Gandhi |
| author_facet | Anandi N. Sheth Charlotte P. Rolle Monica Gandhi |
| author_sort | Anandi N. Sheth |
| collection | DOAJ |
| description | Women and girls comprise nearly half of HIV-infected individuals globally and 20% of new infections in the United States, indicating an urgent need to optimise HIV prevention options in this population. HIV pre-exposure prophylaxis (PrEP) – where antiretrovirals are administered to HIV-non-infected individuals at risk of HIV acquisition – is a promising, female-controlled HIV prevention strategy but has so far been underutilised in women. Clinical trial data demonstrate efficacy of daily oral tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) for reduction of HIV acquisition among women when used consistently. Limited HIV risk perception and suboptimal PrEP awareness among women and healthcare personnel are among the challenges with PrEP delivery for women. Future research into the development of new drugs and delivery systems, and integrating PrEP delivery with reproductive healthcare services, provide opportunities to optimise this prevention strategy for women. |
| first_indexed | 2024-12-14T15:23:01Z |
| format | Article |
| id | doaj.art-6c62e74386294c25a03c6e8bca22d79e |
| institution | Directory Open Access Journal |
| issn | 2055-6640 |
| language | English |
| last_indexed | 2024-12-14T15:23:01Z |
| publishDate | 2016-07-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Journal of Virus Eradication |
| spelling | doaj.art-6c62e74386294c25a03c6e8bca22d79e2022-12-21T22:56:05ZengElsevierJournal of Virus Eradication2055-66402016-07-0123149155HIV pre-exposure prophylaxis for womenAnandi N. Sheth0Charlotte P. Rolle1Monica Gandhi2Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine and Grady Health System, Atlanta, GA, USA; Corresponding author: Anandi N Sheth, Department of Medicine, Division of Infectious Diseases, Emory University, 49 Jesse Hill Junior Drive SE, Atlanta, GA, USADepartment of Medicine, Division of Infectious Diseases, Emory University School of Medicine and Grady Health System, Atlanta, GA, USADepartment of Medicine, Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco (UCSF), San Francisco, CA, USAWomen and girls comprise nearly half of HIV-infected individuals globally and 20% of new infections in the United States, indicating an urgent need to optimise HIV prevention options in this population. HIV pre-exposure prophylaxis (PrEP) – where antiretrovirals are administered to HIV-non-infected individuals at risk of HIV acquisition – is a promising, female-controlled HIV prevention strategy but has so far been underutilised in women. Clinical trial data demonstrate efficacy of daily oral tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) for reduction of HIV acquisition among women when used consistently. Limited HIV risk perception and suboptimal PrEP awareness among women and healthcare personnel are among the challenges with PrEP delivery for women. Future research into the development of new drugs and delivery systems, and integrating PrEP delivery with reproductive healthcare services, provide opportunities to optimise this prevention strategy for women.http://www.sciencedirect.com/science/article/pii/S2055664020304581Pre-exposure prophylaxiswomen's healthHIV prevention |
| spellingShingle | Anandi N. Sheth Charlotte P. Rolle Monica Gandhi HIV pre-exposure prophylaxis for women Journal of Virus Eradication Pre-exposure prophylaxis women's health HIV prevention |
| title | HIV pre-exposure prophylaxis for women |
| title_full | HIV pre-exposure prophylaxis for women |
| title_fullStr | HIV pre-exposure prophylaxis for women |
| title_full_unstemmed | HIV pre-exposure prophylaxis for women |
| title_short | HIV pre-exposure prophylaxis for women |
| title_sort | hiv pre exposure prophylaxis for women |
| topic | Pre-exposure prophylaxis women's health HIV prevention |
| url | http://www.sciencedirect.com/science/article/pii/S2055664020304581 |
| work_keys_str_mv | AT anandinsheth hivpreexposureprophylaxisforwomen AT charlotteprolle hivpreexposureprophylaxisforwomen AT monicagandhi hivpreexposureprophylaxisforwomen |